Overexpression or dysregulation of receptor tyrosine kinases in breast cancer cells leads to accelerated tumor growth, angiogenesis, and metastasis by activating numerous downstream signaling pathways [22]. This evidence concerns the gene NTRK1 and breast carcinoma.